SavedAdd your journal

Journals / Akademik Acil Tıp Dergisi / 2010 / Cilt: 9 - Sayı: 3

Role of homocysteine in ischemic cerebrovascular disease

İskemik Serebrovasküler hastalıkta homosisteinin rolü

Fevzi YILMAZ
Fikret BİLDİK
Ahmet DEMİRCAN
Pages
134–142
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Among the risk factors of stroke, a statistically significant relation between the presence of hypertension in the medical history and high blood pressure in the physical examination was found (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Stroke currently comes third among mortality causes, particularly in developed countries.
📊
Key Findings & Data:Results: Eighty-three adult patients and a group of volunteers consisting of 41 individuals were included in the study.
💡
Conclusion & Impact:Among the risk factors of stroke, a statistically significant relation between the presence of hypertension in the medical history and high blood pressure in the physical examination was found (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Stroke currently comes third among mortality causes, particularly in developed countries. This study has been performed to determine whether a high level of homocysteine is an independent risk factor for ischemic cerebrovascular disease. Materials and Methods: This study was performed in the Adult Emergency Room of Gazi University, Emergency Medicine Department. This study is a controlled prospective study. Kolmogorov-Smirnov, Shapiro-Wilk, Student’s T test, Chi-square, and Fisher’s Exact tests were used in the evaluation of the statistical data. Results: Eighty-three adult patients and a group of volunteers consisting of 41 individuals were included in the study. Among the risk factors of stroke, a statistically significant relation between the presence of hypertension in the medical history and high blood pressure in the physical examination was found (p

Özet

Amaç: Stroke, günümüzde özellikle gelişmiş ülkelerde ölüm sebepleri arasında üçüncü sırada yer almaktadır. Stroke sonrası kalan kognitif ve motor sekeller, üretken bireyleri, psikolojik, fizyolojik ve sosyal açıdan bağımlı hale getirir. Bu durumun ülkeler ekonomisine etkiside oldukça yüksektir. Bu çalışma, iskemik serebrovasküler hastalık için homosistein yüksekliğinin bağımsız bir risk faktörü olup olmadığını belirlemek amacıyla yapılmıştır. Gereç ve Yöntemler: Bu çalışma; Gazi Üniversitesi Tıp Fakültesi Acil Tıp Anabilim Dalı Erişkin Acil Serviste yapılmıştır. Çalışma kontrollü, prospektif bir çalışmadır. İstatistik verileri değerlendirmede Kolmogorov-Smirnov, Shapiro-Wilk, Student’s T testi Ki-kare ve Fisher’s Exact testleri uygulanmıştır. Bulgular: Çalışmaya 83 erişkin hasta ile 41 kişilik gönüllü kontrol grubu alınmıştır. İnme risk faktörlerinden, hastaların özgeçmişinde hipertansiyon hikayesinin olması ve fizik muayenede saptanan yüksek kan basıncı ile inme arasında istatistiksel anlamlı bir ilişki saptanmıştır(p

🔖

Cite This Article

YILMAZ, F., BİLDİK, F., DEMİRCAN, A. (2022). Role of homocysteine in ischemic cerebrovascular disease. Akademik Acil Tıp Dergisi, Cilt: 9 - Sayı: 3, 134–142. https://ajindex.com/articles/431744

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Malmgren R, Warlow C, Bamford J, Sandercock P. Geographical and secular trends in stroke incidence. Lancet 1987; 2: 1196-2000
  2. Warlow CP. Epidemiology of stroke. Lancet 1998; 352 (suppl 3): 1-4
  3. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21: 637-76
  4. Dyken ML, Wolf PA, Barnett HJM et al: Risk Factors in Stroke. Stroke 1984; 15: 1105-11
  5. Adams HP, Biller J, Bradley WG, Daroff RB, Fenichel GM, Marsden CD: İschemic Cerebrovascular Disease. Neurology in Clinical Practice 1996: 993-1031
  6. Rozen R. Methylenetetrahydrofolate reductase in vascular disease, neural tube defects and colon cancer. Chapter 6, Europharma, SA, 1998 avalaible at: (http://www.boehringer-ingelheim.es/workshop methionina/ anglesa/cap6.htm)
  7. Graeme J, Hankey, John W. Eikelboon. Homocysteine and stroke. Current opinion in Neurology 2001; 14: 95-102
  8. Malinow MR. Plasma homocysteine a risk factor arterial occlusive disease. J Nutr Suppl. 4. 1996; 126: 1238-43
  9. Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, [G2]et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997; 277: 1775-81
  10. Wolf PA, Belanger AJ, D’Agostino RB. Management of Risk Factors. Neurologic Clinics 1992; 10: 177-91
  11. Thompson DW, Furlan AJ. Clinical Epidemiology of Stroke. Neurologic Clinics 1996; 14: 309-15.[G3] 12. Mc Cully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis 1975; 22: 215-27
  12. Refsum H, Ueland PM, Nygard O, Vollset SE[G4]. Homocysteine and cardiovascular disease. Ann. Rev. Med 1998; 49: 31-62
  13. Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ[G5]. Cigarette Smoking as a Risk Factor for Stroke The Framingham Study. JAMA 1988; 259: 1025-9
  14. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. Br Med J 1989; 298: 789-94
  15. Adams HP, Butter MJ, Biler J, Toffol GJ. Nonhemorrhagic cerebral infarction in young adults. Arch Neurol 1986; 43: 793-6
  16. Toumilehto J, Bonita R, Steward A, Nissinen A, Salonen JT. [G6] Hypertension, cigarette smoking, and the decline in stroke incidence in eastern Finland. Stroke 1991; 22: 7-11
  17. Wilking SV, Belanger A, Kannel WB, D’Agostino RB, Steel K[G7]. Determinants of isolated systolic hypertension. JAMA 1988; 260: 3451-5
  18. Davies L, Wilmshurst EG, McElduff A, Gunton J, Clifton-Bligh P, Fulcher GR[G8]. The relationship among homocysteine,